Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Sep 7, 2011


AssureRx Health has appointed C. Anthony Altar as senior vice president and chief science officer; Karen Schellin as vice president of finance; and Alexander Burgess as vice president of marketing.

Altar joins the firm from Alere, where he led a collaboration with the Blanchette Rockefeller Neuroscience Institute to develop diagnostic assays for Alzheimer's-oriented dementia. He has also held research and management positions at Ciba-Geigy, Genentech, Regeneron Pharmaceuticals, Otsuka, and Psychiatric Genomics. He holds a PhD in psychology from the University of California, Santa Barbara.

Schellin was most recently associate vice president of operations for EyeMed Vision Care. She holds a BA in business administration from Northern Kentucky University and is a certified public accountant.

Burgess was most recently the director of corporate marketing at MedAssurant. Before that, he was vice president of marketing at DocSite and a regional vice president of sales for ELM Exchange. Burgess has a BA in political science from the Military College of South Carolina.

CombiMatrix announced this week that Jeff Hayes is its new director of sales focusing on oncology products. Bringing 20 years of experience in biopharmaceuticals and cancer diagnostics, Hayes previously held marketing management positions at Schering-Plough, Eli Lilly, LabCorp subsidiary US Labs, and PLUS Diagnostics.

Separately, Daniel Forche had given notice of his resignation as senior VP of sales and marketing for Combimatrix Diagnostics to pursue other opportunities.

The Jackson Laboratory announced that cancer biologist Edison Liu, current executive director of the Genome Institute of Singapore, will take over the top spot at the non-profit institute as its new president and CEO.

Liu founded the Singapore institute in 2001, and before that he was scientific director of the National Cancer Institute's Division of Clinical Sciences.

The Jackson Lab has been looking for a new leader since Rick Woychik departed last January to become deputy director of the National Institute of Environmental Health Sciences in Research Triangle Park, NC.

Kevin McKernan has founded Medicinal Genomics and is also now serving as its CEO. Most recently, he was the head of R&D for Ion Torrent at Life Technologies. He also served as Life Tech's VP of advanced R&D and as a distinguished scientific fellow at Applied Biosystems.

McKernan also founded Agencourt Bioscience, which was subsequently acquired by Beckman Coulter, and Agencourt Personal Genomics, which was acquired by Applied Biosystems.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.